NDC 66715-9752-03 - Advil Liqui-Gels
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 66715-9752
- Requested NDC
- 66715-9752-03
- Package NDCs from labels
- 66715-9752-2, 66715-9752-3, 66715-9752-03
- Manufacturer
- Lil Drug Store Products, Inc
- Effective date
- 2024-03-27
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Advil Liqui-Gels - Lil Drug Store Products, Inc | Lil Drug Store Products, Inc | 2024-03-27 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 66715-9752-2 | Advil Liqui-Gels | 2 in 1 CARTON | CAPSULE, LIQUID FILLED | 2 | 8 | |
| 66715-9752-2 | Advil Liqui-Gels | 2 in 1 POUCH | CAPSULE, LIQUID FILLED | 2 | 8 | |
| 66715-9752-3 | Advil Liqui-Gels | 3 in 1 CARTON | CAPSULE, LIQUID FILLED | 3 | 8 | |
| 66715-9752-3 | Advil Liqui-Gels | 2 in 1 POUCH | CAPSULE, LIQUID FILLED | 2 | 8 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 66715-9752 | ADVIL LIQUI-GELS (IBUPROFEN) CAPSULE, LIQUID FILLED [LIL DRUG STORE PRODUCTS, INC] | 8 | Current NDC, Legacy NDC, 4 package rows | 20240328_ba5a9a04-993e-4fd6-bb40-6edfdfb69b34.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Garzulys | INSULIN ASPART-FSAN | Meitheal Pharmaceuticals Inc. | 30c64769-d2f7-4604-ac9e-2a6bc09506c9 | 2026-07-31 | Warnings, Adverse reactions | 059QF0KO0R |
| Ibuprofen | IBUPROFEN | Ascend Laboratories, LLC | 7c7b815b-d6f5-4ce6-b37f-f35d5c9f3254 | 2026-07-29 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Amneal Pharmaceuticals LLC | 17577b3b-e755-45d1-8b53-775d058578b2 | 2026-07-29 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
| IBUPROFEN | IBUPROFEN | Amazon.com Services LLC | b5a47efe-222f-4cbd-b649-caafd16a0829 | 2026-07-29 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Harris Teeter | 637210f0-6494-4656-8b2b-14d7476cb127 | 2026-07-29 | Warnings | WK2XYI10QM |
| IBUPROFEN | IBUPROFEN | Harris Teeter | 9d5c994a-8363-4ddb-956c-e12b79a32a58 | 2026-07-29 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Harris Teeter | 87ffbf01-54de-45a8-b2a3-367d21927882 | 2026-07-29 | Warnings | 310964 WK2XYI10QM |
| IBUPROFEN | IBUPROFEN | Harris Teeter | 14515409-736f-4119-b6a0-cb19ee2e948e | 2026-07-29 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Harris Teeter | 1fa28cb4-ae7b-4fa9-ae64-9bd8ccfcc633 | 2026-07-29 | Warnings | WK2XYI10QM |
| ADVIL PM | DIPHENHYDRAMINE HCL, IBUPROFEN | Haleon US Holdings LLC | 405afdb4-c157-1d88-f232-848063ba4714 | 2026-07-29 | Warnings | WK2XYI10QM |
| ADVIL COLD AND SINUS | IBUPROFEN, PSEUDOEPHEDRINE HYDROCHLORIDE | Haleon US Holdings LLC | 0da9ed22-bfb4-d61b-110b-0c7760332a98 | 2026-07-29 | Warnings | WK2XYI10QM |
| ADVIL MIGRAINE | IBUPROFEN | Haleon US Holdings LLC | e4a6219d-4ad4-0119-4cf8-7fc39b4b5979 | 2026-07-29 | Warnings | NDA020402 731533 310964 WK2XYI10QM |
| Advil | IBUPROFEN | Haleon US Holdings LLC | 1f01c10a-9434-91a4-2ee4-352315a6b610 | 2026-07-29 | Warnings | NDA020402 731533 310964 WK2XYI10QM |
| DECONIMO Reconstitution | DECONIMO RECONSTITUTION | Image Amazon LLC | 57ab9b1c-9a18-3786-e063-6394a90a2c63 | 2026-07-28 | Warnings | 059QF0KO0R |
| Ibuprofen | IBUPROFEN | H E B | 21567c0f-abba-4a40-a0b9-5ce49b3d9648 | 2026-07-28 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | PD-Rx Pharmaceuticals, Inc. | 656658cc-8cf0-42b6-af4f-4e3ab7648625 | 2026-07-27 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Shield Pharmaceuticals Corp | 1ca722bb-940e-4b3e-9561-d87e2feb1ff8 | 2026-07-24 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Shield Pharmaceuticals Corp | fc6c29b4-f1b3-4cfe-8c96-564d083be39c | 2026-07-24 | Warnings | WK2XYI10QM |
| childrens ibuprofen | IBUPROFEN | Rite Aid Corporation | 26bccfc1-bc8d-4241-a078-c760048951c9 | 2026-07-24 | Warnings | WK2XYI10QM |
| IBUPROFEN | IBUPROFEN | HF Acquisition Co LLC, DBA HealthFirst | 574b6f15-70bc-fca7-e063-6294a90a0455 | 2026-07-23 | Warnings | WK2XYI10QM |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.